Who owns Enochian Biosciences Inc?
- Ticker: RENB
- CUSIP Number: 29350e104
Tip: Access positions for across all investors
Analyze quarterly positions in Enochian Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enochian Biosciences stock
Who bought or sold Enochian Biosciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 6.5M | $5.4M | 80% | Dec 2024 |
|
| Vanguard Group | 5.7M | $4.8M | 0% | Dec 2024 |
|
| Geode Capital Management | 2.3M | $1.9M | 48% | Dec 2024 |
|
| State Street Corporation | 2.1M | $1.7M | 56% | Dec 2024 |
|
| Northern Trust | 889k | $743k | 49% | Dec 2024 |
|
| UBS Group | 764k | $639k | 1544% | Dec 2024 |
|
| Morgan Stanley | 368k | $308k | 3% | Dec 2024 |
|
| Goldman Sachs Group | 365k | $305k | 292% | Dec 2024 |
|
| Charles Schwab Investment Management | 362k | $303k | 82% | Dec 2024 |
|
| Jpmorgan Chase & Co | 354k | $296k | 280% | Dec 2024 |
|
| Bank of New York Mellon | 224k | $187k | 137% | Dec 2024 |
|
| Citigroup | 188k | $157k | 207% | Dec 2024 |
|
| Barclays | 180k | $150k | 159% | Dec 2024 |
|
| Nuveen Asset Management | 152k | $127k | 129% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 127k | $107k | 100% | Dec 2024 |
|
| Rhumbline Advisers | 113k | $94k | 123% | Dec 2024 |
|
| Commonwealth Equity Services | 102k | $85k | 0% | Dec 2024 |
|
| Cantor Fitzgerald, L. P. | 100k | $48k | 100% | Sep 2024 |
|
| Susquehanna International | 99k | $83k | 108% | Dec 2024 |
|
| Bank of America Corporation | 92k | $77k | 4% | Dec 2024 |
|
| MetLife Investment Advisors | 76k | $63k | 100% | Dec 2024 |
|
| Wells Fargo & Company | 59k | $49k | 225% | Dec 2024 |
|
| Corebridge Financial | 58k | $48k | 100% | Dec 2024 |
|
| Citadel Advisors | 54k | $45k | 357% | Dec 2024 |
|
| New York State Common Retirement Fund | 53k | $44k | -21% | Dec 2024 |
|
| SG Americas Securities | 52k | $43k | 193% | Dec 2024 |
|
| Manufacturers Life Insurance Company | 46k | $38k | 100% | Dec 2024 |
|
| T. Rowe Price Associates | 45k | $38k | 183% | Dec 2024 |
|
| Alliancebernstein | 38k | $32k | 0% | Dec 2024 |
|
| Ing Investment Management | 35k | $30k | 100% | Dec 2024 |
|
| ProShare Advisors | 33k | $27k | 100% | Dec 2024 |
|
| Invesco | 29k | $24k | 27% | Dec 2024 |
|
| MSA Advisors | 25k | $12k | 0% | Sep 2024 |
|
| Two Sigma Investments | 24k | $20k | 6% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 24k | $11k | 100% | Sep 2024 |
|
| JustInvest | 21k | $17k | -7% | Dec 2024 |
|
| Two Sigma Securities | 17k | $14k | 100% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 17k | $14k | 59% | Dec 2024 |
|
| William Blair $ Company | 16k | $14k | 0% | Dec 2024 |
|
| FMR | 15k | $13k | 278% | Dec 2024 |
|
| Hsbc Holdings | 14k | $12k | -76% | Dec 2024 |
|
| Abel Hall | 12k | $10k | 100% | Dec 2024 |
|
| Tower Research Capital | 12k | $10k | -26% | Dec 2024 |
|
| Summit Investment Advisors | 12k | $10k | 153% | Dec 2024 |
|
| Legal & General Group | 12k | $9.9k | 138% | Dec 2024 |
|
| Cibc World Markets | 11k | $9.0k | 100% | Dec 2024 |
|
| AQR Capital Management | 11k | $8.8k | 100% | Dec 2024 |
|
| Jane Street | 10k | $8.6k | -51% | Dec 2024 |
|
| XTX Topco | 10k | $8.5k | -47% | Dec 2024 |
|
| California State Teachers Retirement System | 8.6k | $7.2k | 143% | Dec 2024 |
|
| Simplex Trading | 6.1k | $5.0k | 620% | Dec 2024 |
|
| Russell Investments | 3.2k | $2.7k | 100% | Dec 2024 |
|
| Amalgamated Bank | 1.7k | $1.0k | 0% | Dec 2024 |
|
| Sterling Capital Management | 1.4k | $1.1k | 1435% | Dec 2024 |
|
| NISA Investment Advisors | 647.00 | $541.021400 | 699% | Dec 2024 |
|
| CWM | 241.00 | $0 | 58% | Dec 2024 |
|
| CNB Bank | 15.00 | $13.000500 | 0% | Dec 2024 |
|
| SBI Securities | 10.00 | $8.000000 | 100% | Dec 2024 |
|
Who sold out of Enochian Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sunrise Partners Limited Partnership | Sep 2024 | 17k | $8.2k |
| Y-Intercept | Sep 2024 | 12k | $6.0k |
| Victory Capital Management | Sep 2024 | 10k | $5.0k |
| Royal Bank of Canada | Sep 2024 | 5.6k | $0 |